top of page

Drug Therapy for Addiction | AQA A-Level Psychology Revision

Aug 7
26 min read

Updated: Sep 26

For 7182 specification, first teach in September 2025


AQA A-Level Psychology | Free Revision Notes


Estimated study time: 65 to 80 minutes




Drug therapy for addiction A-Level Psychology revision examines how medication may reduce craving, withdrawal and the rewarding effects of an addictive substance. Rather than relying only on willpower, drug treatments alter biological processes involved in physical dependence and reinforcement.

You will explore nicotine replacement therapy and methadone as examples of substitution treatments, linking each intervention to receptors, neurochemistry and withdrawal. You will also evaluate side effects, dependency, relapse and whether medication addresses the psychological and social causes of addiction. AQA requires drug therapy as a way of reducing addiction but does not prescribe one fixed list of medicines.


Learning Objectives šŸŽÆ

By the end of this revision page, you should be able to:

  • DefineĀ drug therapy as a way of reducing addiction.

  • ExplainĀ how medication may reduce withdrawal and craving.

  • ExplainĀ nicotine replacement therapy.

  • ExplainĀ how methadone may be used to treat opioid dependence.

  • LinkĀ drug therapy with biological explanations of addiction.

  • ApplyĀ drug treatment to unfamiliar addiction scenarios.

  • EvaluateĀ the appropriateness and effectiveness of drug therapy.

  • DistinguishĀ short-term symptom control from lasting recovery.


Revision Notes šŸ“š


Drug Therapy for Addiction A-Level Psychology Revision Focus

Drug therapyĀ involves using medication to reduce or manage addictive behaviour.

A drug treatment may aim to:

  • Reduce physical withdrawal.

  • Reduce craving.

  • stabilise neurochemical activity.

  • Prevent a sudden fall in receptor stimulation.

  • Reduce the rewarding effects of the addictive substance.

  • Support gradual detoxification.

  • Lower the risk of immediate relapse.

  • Make psychological treatment easier to engage with.

Drug therapy is a biological interventionĀ because it acts on physiological processes such as:

  • Receptors.

  • Neurotransmitters.

  • The brain’s reward pathway.

  • Substance metabolism.

  • Physical dependence.

  • Withdrawal.

The AQA specimen mark scheme states that an answer about drug therapy should normally identify a named drug and its mode of action. It also identifies side effects and dependency, including dependency on methadone, as relevant limitations.


AQA Does Not Require One Fixed Drug List

The current specification names drug therapyĀ without prescribing particular medications.

This means an effective examination answer should:

  1. Name an appropriate drug or treatment.

  2. Identify the addiction being treated.

  3. Explain the biological mode of action.

  4. Explain how this reduces addictive behaviour.

  5. Evaluate suitability, side effects and long-term outcomes.

This lesson uses two clear examples:

  • Nicotine replacement therapy, or NRT, for nicotine addiction.

  • MethadoneĀ for opioid dependence.

These examples illustrate the biological principles AQA may assess.


The Biological Basis of Drug Therapy


Addiction and Neurochemical Adaptation

Repeated use of an addictive substance can change how the brain and body function.

The person may develop:

  • Physical dependence.

  • Tolerance.

  • Withdrawal syndrome.

  • Craving.

  • Altered receptor activity.

  • Changes within reward pathways.

When the substance is stopped suddenly:

  1. Receptor stimulation falls.

  2. The adapted nervous system becomes unbalanced.

  3. Withdrawal symptoms appear.

  4. Craving increases.

  5. The person is motivated to use the substance again.

  6. Relief from withdrawal negatively reinforces further use.

Drug therapy attempts to interrupt this cycle.


A General Drug-Therapy Sequence

A biological treatment may operate through the following process:

Medication acts on the relevant receptor or neurochemical system → withdrawal and craving are reduced → immediate pressure to use the addictive substance decreases → the person has a greater opportunity to remain abstinent or reduce use

Medication does not necessarily remove every cause of addiction.

It may primarily treat:

  • The physical consequences of dependence.

  • Neurochemical craving.

  • Biological reward.

  • The early difficulty of stopping.


Agonists and Antagonists

Drug therapies can be understood through their effects on receptors.


Agonist

An agonistĀ is a substance that:

  • Binds to a receptor.

  • Activates the receptor.

  • Produces a biological response.

A substitute agonist may activate the same system as an addictive drug but in a:

  • Safer form.

  • More controlled dose.

  • Slower manner.

  • Less reinforcing pattern.

The aim is to prevent severe withdrawal without recreating the same harmful method of substance use.


Antagonist

An antagonistĀ is a substance that:

  • Binds to a receptor.

  • Blocks or reduces the action of another substance.

  • Does not activate the receptor in the same way as a full agonist.

An antagonist may make the addictive substance:

  • Less rewarding.

  • Less pleasurable.

  • Less able to activate the reward system.


Partial Agonist

A partial agonistĀ activates a receptor but produces a weaker response than a full agonist.

This may:

  • Reduce withdrawal.

  • Reduce craving.

  • Prevent the addictive substance from producing its usual full effect.

For AQA, the essential skill is not memorising every receptor classification. It is explaining how changing biological activity reduces addiction.


Substitution Therapy


What Is Substitution?

Substitution therapyĀ replaces a harmful or uncontrolled addictive substance with a medically managed alternative.

The substitute may:

  • Act on similar receptors.

  • Prevent withdrawal.

  • Be given in a measured dose.

  • Produce slower biological effects.

  • Be gradually reduced.

  • Avoid some harms associated with the original substance.

Examples include:

  • Nicotine delivered through an NRT product rather than cigarette smoke.

  • Methadone replacing illicit opioid use.


Why Slower Delivery May Matter

Addictive substances can be strongly reinforcing when they produce rapid changes in the brain.

A controlled substitute may produce:

  • A slower increase in drug level.

  • A steadier level over time.

  • Fewer rapid peaks and falls.

  • Less intense reward.

  • Reduced withdrawal between doses.

The person receives enough stimulation to manage dependence without repeating the original pattern of use.


Nicotine Replacement Therapy


What Is Nicotine Replacement Therapy?

Nicotine replacement therapy, or NRT, provides nicotine without requiring the person to smoke cigarettes.

NRT products include:

  • Patches.

  • Gum.

  • Lozenges.

  • Inhalers.

  • Mouth sprays.

  • Nasal sprays.

The NHS explains that NRT gives the body lower amounts of nicotine without the dangerous chemicals found in cigarette smoke. It is used to manage craving and withdrawal while a person stops smoking.


NRT Does Not Immediately Remove All Nicotine

A common misunderstanding is that treatment must remove nicotine from the body immediately.

NRT instead separates:

  • Nicotine dependence.

  • Cigarette smoking.

  • Exposure to the other chemicals in cigarette smoke.

The person receives nicotine through a controlled product while discontinuing smoking.


How NRT Works

The process is:

  1. The smoker stops or reduces cigarette use.

  2. Nicotine from cigarettes falls.

  3. An NRT product supplies a controlled nicotine dose.

  4. Nicotinic acetylcholine receptors continue receiving some stimulation.

  5. Withdrawal symptoms become less intense.

  6. Craving becomes more manageable.

  7. The person is less strongly motivated to smoke for relief.

  8. Nicotine dosage can later be reduced.

The NHS states that NRT products help with cravings and withdrawal by supplying nicotine in a safer, controlled form.


Linking NRT to Nicotinic Receptors

Nicotine binds to nicotinic acetylcholine receptors.

Regular smoking causes the nervous system to adapt to repeated nicotine exposure.

When smoking stops:

  • Receptor stimulation decreases.

  • Dopamine-related reward activity changes.

  • Withdrawal and craving may occur.

NRT continues some receptor stimulation without cigarette smoking.

This reduces the sudden biological change produced by complete nicotine removal.


Linking NRT to Dopamine

Nicotine normally stimulates the brain’s reward pathway, including dopamine activity.

NRT may provide enough nicotine to:

  • Reduce withdrawal-related craving.

  • Prevent an abrupt fall in accustomed stimulation.

  • Help the person function while cigarette use stops.

It does not aim to reproduce the rapid, repeated reinforcement pattern associated with smoking.


Positive and Negative Reinforcement

Smoking may be maintained through:

Positive reinforcement

Nicotine produces a rewarding effect.

Negative reinforcement

Smoking removes unpleasant withdrawal.

NRT mainly targets the second process.

By reducing withdrawal, it weakens the need to smoke in order to obtain relief.

The person may still experience psychologically conditioned cravings when exposed to:

  • A morning coffee.

  • Friends who smoke.

  • Alcohol.

  • Work breaks.

  • Stress.

  • Cigarette-related objects.

NRT does not automatically extinguish these associations.


Slow-Acting and Fast-Acting NRT


Slow-Acting NRT

A nicotine patch releases nicotine gradually.

It aims to provide:

  • A relatively steady level.

  • Background control of withdrawal.

  • Support across several hours.

The NHS describes patches as slow-acting products that release nicotine steadily.


Fast-Acting NRT

Products such as gum or sprays deliver nicotine more quickly.

They may be used when:

  • A sudden craving occurs.

  • A smoking cue is encountered.

  • Withdrawal increases unexpectedly.

The NHS distinguishes fast-acting products such as sprays, inhalers, gum and lozenges from slow-acting patches.


Why the Forms May Be Combined

A slow-acting product can provide baseline support.

A fast-acting product can respond to a sudden craving.

The psychological logic is:

Steady control of withdrawal + rapid response to high-risk moments

This may be more helpful than relying on one method alone.

For an AQA answer, the key point is the biological principle, not detailed prescribing instructions.


Gradual Reduction

NRT can be reduced gradually as the person becomes accustomed to lower nicotine exposure.

This may involve:

  • Moving to a lower-strength product.

  • Reducing how often a fast-acting product is used.

  • Extending the time between doses.

  • Eventually stopping nicotine completely.

Gradual reduction is intended to avoid a sudden return of severe withdrawal.


NRT and Extinction of Smoking Behaviour

While NRT manages physical dependence, the person is no longer repeatedly performing the full smoking routine.

This may allow smoking-related behaviours to weaken, such as:

  • Lighting a cigarette.

  • Holding it.

  • Inhaling smoke.

  • Taking a cigarette break.

  • Purchasing cigarette packets.

However, environmental cues may continue to trigger craving, especially if psychological treatment is not included.


Applying NRT

Consider this scenario:

Aisha has smoked for ten years. When she tries to stop, she becomes restless, irritable and unable to concentrate. She usually returns to smoking within a day because a cigarette makes these symptoms disappear.

NRT could help because:

  • Aisha’s symptoms indicate nicotine withdrawal.

  • A patch could provide a steady controlled nicotine dose.

  • Nicotinic receptors would continue receiving some stimulation.

  • Withdrawal and craving should become easier to manage.

  • Smoking would no longer be required to remove the discomfort.

  • The negative reinforcement maintaining smoking would be weakened.

  • The nicotine dose could later be reduced.

A complete application should explain both the symptom and the biological mechanism.


Nicotine-Free Medication

Some smoking treatments do not contain nicotine.

They may act by:

  • Reducing nicotine’s rewarding effect.

  • Reducing craving.

  • Reducing withdrawal.

  • Changing neurotransmitter activity.

The NHS describes nicotine-free medicines such as varenicline, cytisine and bupropion. It states that these medicines may block or alter nicotine-related processes so smoking is less rewarding and cravings are reduced.

The current AQA specification does not require students to memorise these particular names. The examination priority remains:

Named treatment + biological action + effect on addiction

Methadone


What Is Methadone?

MethadoneĀ is a long-acting opioid medicine used in the treatment of dependence on heroin and other opioids.

It may be used as:

  • Maintenance therapy.

  • Part of gradual detoxification.

The NHS states that methadone reduces opioid withdrawal symptoms and cravings.

AQA’s specimen mark scheme explicitly accepts methadone as a drug-therapy example and identifies possible dependency as a limitation.


Methadone as an Agonist Substitute

Methadone activates opioid receptors.

It can therefore prevent the sudden receptor under-stimulation that would otherwise follow heroin cessation.

The general process is:

  1. A person dependent on heroin stops or reduces heroin use.

  2. Heroin-related opioid-receptor stimulation would normally fall sharply.

  3. Methadone provides controlled opioid-receptor activation.

  4. Withdrawal symptoms are reduced.

  5. Craving is reduced.

  6. Illicit opioid use becomes less immediately necessary.

  7. The person may remain on maintenance treatment or gradually reduce the dose.

NICE recommends methadone and buprenorphine as maintenance options for opioid dependence and states that treatment choice should be made according to the individual’s circumstances and risks.


Why Methadone May Be Less Reinforcing

Methadone is longer acting than heroin.

This may produce:

  • More stable receptor activation.

  • Fewer rapid neurochemical peaks and falls.

  • Reduced withdrawal between doses.

  • Less repeated drug-seeking across the day.

The NHS explains that methadone is long acting and reduces heroin withdrawal and craving without producing the same experience as heroin.


Maintenance Therapy

During maintenance therapy, the person switches from the illicit opioid to a medically managed methadone dose.

The aims may include:

  • Stabilising dependence.

  • Reducing illicit use.

  • Reducing withdrawal.

  • Reducing craving.

  • Creating stability for wider treatment.

  • Reducing harmful drug-seeking behaviour.

Maintenance does not necessarily mean that physical dependence has ended.

It means that the dependence is being medically managed.


Detoxification

During detoxification, the person moves from the original opioid to methadone and then gradually reduces methadone.

The aim is eventual abstinence.

The process must be gradual because abruptly stopping methadone can itself produce withdrawal.

The NHS notes that methadone is addictive and should be reduced gradually under professional supervision.


Applying Methadone

Lewis is dependent on heroin. When he stops, he experiences severe restlessness, sweating, nausea and craving. These symptoms lead him to use heroin again.

Methadone may reduce Lewis’s addiction because:

  • The symptoms indicate opioid withdrawal.

  • Methadone activates opioid receptors.

  • This prevents the sudden loss of receptor stimulation.

  • Withdrawal and craving are reduced.

  • Heroin is no longer required to remove the symptoms.

  • Lewis may receive a stable, supervised dose.

  • The dose may later be reduced as part of detoxification.


Drug Therapy and Biological Explanations


Treating the Proposed Cause

Biological explanations propose that addiction involves:

  • Receptors.

  • Neurotransmitters.

  • Reward pathways.

  • Neuroadaptation.

  • Dependence.

  • Withdrawal.

Drug therapy directly targets these processes.

Biological explanation

Drug-therapy response

Receptor systems have adapted to repeated substance use

A substitute drug maintains controlled receptor stimulation

Falling stimulation produces withdrawal

Medication reduces the sudden biological change

Withdrawal motivates renewed use

Reduced withdrawal lowers immediate relapse pressure

The substance activates reward pathways

Blocking medication may reduce the rewarding effect

Rapid peaks reinforce repeated use

Long-acting medication may provide steadier activity

Individual biology affects addiction

Treatment may be selected according to the individual


NRT and the Neurochemical Explanation

The neurochemical explanation states that nicotine acts on nicotinic receptors and influences dopamine-related reward.

NRT is consistent with this because it:

  • Supplies controlled nicotine.

  • Maintains limited receptor stimulation.

  • Reduces withdrawal.

  • Helps the nervous system adapt to lower nicotine levels.

This practical application increases the usefulness of the neurochemical explanation.


Methadone and Physical Dependence

Methadone is consistent with a biological account of opioid dependence because it:

  • Acts on opioid receptors.

  • Reduces withdrawal.

  • Reduces craving.

  • Allows controlled stabilisation.

It treats the biological state that maintains illicit drug use through negative reinforcement.


Biological Treatment Does Not Prove a Purely Biological Cause

A medication can be effective without addiction being entirely biological.

For example:

  • NRT may reduce nicotine withdrawal.

  • The person may still relapse when drinking coffee.

  • Friends may still offer cigarettes.

  • Stress may still trigger craving.

  • The smoking ritual may remain conditioned.

Drug success supports the importance of a biological mechanism.

It does not show that learning, cognition and social factors are irrelevant.


Drug Therapy and Physical Dependence

Drug therapy is particularly well suited to physical dependence.

It can target:

  • Withdrawal.

  • Craving linked to neurochemical adaptation.

  • Receptor activity.

  • Physiological instability.

This makes it more naturally applicable to substance addictions than to many behavioural addictions.


Psychological Dependence

Drug therapy may be less effective at directly changing beliefs such as:

  • ā€œI cannot relax without smoking.ā€

  • ā€œGambling is the only exciting part of my life.ā€

  • ā€œI need the substance when I feel stressed.ā€

  • ā€œA win is due after several losses.ā€

These are forms of psychological dependence or cognitive distortion.

Medication may reduce biological pressure while leaving the person’s learned beliefs unchanged.


Drug Therapy and Gambling Addiction

Gambling addiction does not involve withdrawal from an ingested substance in the same way as nicotine or opioid dependence.

Its maintenance may involve:

  • Variable reinforcement.

  • Cognitive bias.

  • Excitement.

  • Social reward.

  • Escape from distress.

  • Reward-system activity.

Drug treatment has therefore been investigated for some behavioural addictions, but its application is less straightforward than treatment for substance dependence.

The supplied AQA materials do not specify a required medication protocol for gambling addiction. In the June 2024 applied question about a gambler, the mark scheme noted that drug therapy did not lend itself easily to application.

For a gambling scenario, behavioural or cognitive treatments may provide more direct application because they can address:

  • Reinforcement schedules.

  • Irrational beliefs.

  • Gambling triggers.

  • Coping skills.


Drug Therapy and Learning Theory

Learning theory proposes that addiction is maintained through:

  • Positive reinforcement.

  • Negative reinforcement.

  • Conditioned cues.

Drug therapy may reduce negative reinforcement by reducing withdrawal.

For example:

NRT reduces withdrawal, so smoking is no longer required to remove irritability and craving.

However, medication may not remove conditioned associations.

A person might still crave a cigarette when:

  • Finishing a meal.

  • Entering a pub.

  • Seeing another person smoke.

  • Taking a work break.

This means drug therapy and learning-based interventions may be combined.


Drug Therapy and Cognitive Explanations

Drug therapy does not directly challenge irrational beliefs.

For example, it would not teach a gambler that:

  • Previous losses do not make a win due.

  • A lucky ritual does not control an outcome.

  • Near misses remain losses.

  • Remembered wins do not represent overall profitability.

These distortions are considered in cognitive bias and gambling addiction.

Cognitive behaviour therapy may therefore be more appropriate when distorted thinking is central.


Drug Therapy and Social Influences

Medication cannot directly change:

  • Peer pressure.

  • Family modelling.

  • Availability.

  • Social identity.

  • Stressful relationships.

  • Group norms.

A person may receive effective medication but return to an environment where:

  • Everyone smokes.

  • Substance use receives approval.

  • Gambling is a group activity.

  • Support for abstinence is limited.

Social circumstances can therefore affect whether biological improvement is maintained.


Evaluating Drug Therapy


Strength: It Directly Targets Biological Dependence

A major strength is that drug therapy targets physical mechanisms maintaining addiction.

For a nicotine-dependent smoker:

  • Withdrawal is not merely a belief.

  • The nervous system has adapted to nicotine.

  • Falling nicotine levels produce real discomfort.

  • Medication can reduce this biological pressure.

For an opioid-dependent person:

  • Methadone can reduce withdrawal and craving through controlled opioid-receptor activity.

This makes drug therapy appropriate where physical dependence is severe.


Strength: It Can Reduce Immediate Relapse Pressure

The early stages of stopping may involve intense:

  • Craving.

  • Irritability.

  • Restlessness.

  • Anxiety.

  • Concentration problems.

  • Physical discomfort.

If medication reduces these effects, the person may be better able to:

  • Avoid the addictive substance.

  • Attend treatment.

  • Continue working.

  • Use coping strategies.

  • Make deliberate decisions.

Drug therapy may therefore create a period of stability during which wider change becomes possible.


Strength: It Is Based on a Clear Mode of Action

Drug therapy has a biological rationale.

A high-quality explanation can identify:

  • The receptor system.

  • Whether the treatment activates or blocks it.

  • How withdrawal or reward changes.

  • Why addictive behaviour becomes less likely.

This produces testable predictions.

For example:

If NRT reduces nicotine withdrawal, treated smokers should report less severe craving than they would during unsupported abrupt cessation.

The AQA specimen mark scheme expects students to explain a named drug and its mode of action rather than merely state that medication is given.


Strength: Practical and Accessible

Taking a medication may require less psychological insight than therapy requiring the person to:

  • Discuss emotional experiences.

  • Analyse beliefs.

  • Imagine aversive consequences.

  • Complete extensive homework.

  • Role-play high-risk situations.

This can make drug therapy suitable for someone who:

  • Is not ready for intensive psychological work.

  • Has severe physical withdrawal.

  • Needs immediate stabilisation.

  • Has limited access to regular therapy.

However, medication still requires adherence and appropriate professional support.


Strength: Harm Reduction

Substitution treatment may reduce harm even before total abstinence is achieved.

For example:

  • NRT supplies nicotine without cigarette smoke.

  • Methadone replaces uncontrolled illicit opioid use with a medically managed dose.

The aim may initially be:

  • Safer use.

  • Reduced exposure to harmful methods.

  • Greater stability.

  • Reduced risk associated with obtaining the original substance.

  • Preparation for later abstinence.

NICE treats methadone as part of maintenance care and emphasises case-by-case assessment and supportive treatment.


Abstinence Is Not the Only Outcome

Treatment success might include:

  • Reduced use.

  • Reduced craving.

  • Reduced withdrawal.

  • Improved health.

  • Improved social functioning.

  • Greater treatment engagement.

  • Eventual abstinence.

Judging treatment only by immediate total abstinence may overlook meaningful harm reduction.


Strength: Drug Therapy Can Support Other Treatments

Medication may make it easier to engage with:

  • CBT.

  • Support groups.

  • Relapse-prevention work.

  • Family interventions.

  • Skills training.

  • Behavioural treatment.

For example:

  1. NRT reduces physical craving.

  2. CBT challenges the belief that smoking is needed for stress.

  3. Cue-management strategies weaken conditioned associations.

  4. Social support helps maintain abstinence.

NICE notes that pharmacological treatment for opioid dependence should be provided as part of supportive care, and psychological approaches remain important alongside medication.


Limitation: Side Effects

Drug therapy may produce unwanted effects.

The nature and severity of side effects depend on:

  • The particular medication.

  • Dose.

  • Duration.

  • Physical health.

  • Other medicines or substances.

  • Individual sensitivity.

Side effects can reduce:

  • Adherence.

  • Quality of life.

  • Willingness to continue treatment.

  • Overall cost-effectiveness.

A treatment must therefore be judged through a cost-benefit analysis.

AQA explicitly identifies side effects as a relevant limitation of drug therapy.


Cost-Benefit Judgement

A side effect does not automatically make a treatment inappropriate.

The relevant comparison is:

Are the treatment’s risks less serious than the likely risks of untreated addiction?

For someone at high risk from continued substance use, a manageable side effect may be acceptable.

For someone with a different health profile, another treatment may be more appropriate.


Limitation: Dependence on the Substitute Drug

Substitution therapy may be criticised for replacing one dependency with another.

For example:

  • NRT continues nicotine exposure.

  • Methadone is itself an opioid.

  • Physical dependence may remain during maintenance treatment.

The NHS states that methadone is addictive and must be reduced gradually to prevent withdrawal.

AQA’s specimen mark scheme specifically identifies dependency on methadone as a possible limitation.


Is Substitution Necessarily a Failure?

The criticism requires balance.

Although physical dependence may continue, the substitute may be:

  • More controlled.

  • Longer acting.

  • Medically supervised.

  • Less connected with harmful methods of use.

  • Easier to reduce gradually.

  • Supportive of social stability.

The treatment may therefore reduce harm even if immediate drug-free abstinence is not achieved.


Limitation: Drug Therapy May Treat Symptoms Rather Than Causes

Medication may reduce:

  • Withdrawal.

  • Craving.

  • Reward.

It may not address why the addiction developed.

Possible underlying factors include:

  • Chronic stress.

  • Family modelling.

  • Peer influence.

  • Trauma.

  • Cognitive bias.

  • Sensation seeking.

  • Low self-efficacy.

  • Conditioned cues.

  • Social isolation.

When medication ends, these influences may remain.

The person may therefore relapse because the original psychological or environmental causes were never addressed.


Limitation: Conditioned Cues Remain

A smoker may use NRT successfully but still encounter cues such as:

  • Coffee.

  • Alcohol.

  • Social gatherings.

  • Work breaks.

  • The sight of a cigarette packet.

These cues may produce craving through classical conditioning.

Medication that manages physical withdrawal may not extinguish the conditioned association.

This is why relapse may occur even after the drug has reduced biological dependence.


Limitation: Psychological Dependence May Remain

A person may continue believing:

  • ā€œSmoking is part of my identity.ā€

  • ā€œI cannot cope without nicotine.ā€

  • ā€œI need the substance when I feel anxious.ā€

  • ā€œLife is boring without the addictive behaviour.ā€

Drug therapy cannot directly challenge these cognitions.

A treatment such as cognitive behaviour therapy for addiction may be needed to develop:

  • Alternative thoughts.

  • Coping strategies.

  • Assertiveness.

  • Problem-solving.

  • Relapse prevention.


Limitation: Adherence

Medication works only when it is used as intended.

A person may:

  • Forget doses.

  • Stop because of side effects.

  • Use the treatment inconsistently.

  • Continue the original substance.

  • Use the wrong amount.

  • End treatment too early.

Low adherence can make an effective drug appear ineffective.

Alternatively, tightly supervised treatment may produce outcomes that do not generalise to unsupervised everyday use.


Limitation: Individual Differences

People differ in:

  • Dependence severity.

  • Metabolism.

  • Receptor functioning.

  • Health conditions.

  • Side-effect sensitivity.

  • Motivation.

  • Social support.

  • Previous treatment.

  • Co-occurring difficulties.

A medication that works well for one person may be:

  • Ineffective for another.

  • Poorly tolerated.

  • Unsafe.

  • Insufficient on its own.

NICE states that medication for opioid dependence should be selected case by case, considering the person’s history, goals and the balance of risks and benefits.


Limitation: Relapse After Medication Ends

Drug therapy may suppress biological symptoms only while it is being used.

When treatment stops:

  • Withdrawal may return.

  • Craving may increase.

  • Environmental cues remain.

  • Social pressure may reappear.

  • The person may lack coping strategies.

Short-term effectiveness does not guarantee long-term recovery.

A strong evaluation distinguishes:

  • Symptom reduction during treatment.

  • Abstinence after treatment.

  • Long-term relapse.

  • Improved quality of life.


Measuring Effectiveness

Drug therapy can be evaluated using several outcomes.

Outcome

What it measures

Limitation

Self-reported craving

Subjective urge to use

May be affected by social desirability

Withdrawal score

Physical and psychological symptoms

Does not directly show abstinence

Biological test

Presence of a substance or medication

May cover only a limited period

Treatment completion

Adherence

Completion does not prove recovery

Abstinence rate

Avoidance of the substance

May depend on how abstinence is defined

Relapse rate

Return to addictive behaviour

Relapse may be hidden or inconsistently measured

Quality of life

Wider functioning

May be influenced by many other factors

Reduction in use

Harm reduction

Does not equal complete abstinence

No single measure provides a complete picture.


Placebo-Controlled Research

Drug effectiveness may be investigated by comparing:

  • An active medication group.

  • A placebo group.

  • A psychological-treatment group.

  • A combined-treatment group.

A placeboĀ resembles the medication but does not contain its active ingredient.


Strength of Placebo Control

A placebo group helps separate:

  • The pharmacological effect.

  • Expectations about treatment.

  • Attention from professionals.

  • Natural improvement.


Double-Blind Procedure

In a double-blind trial:

  • Participants do not know which treatment they received.

  • Researchers dealing directly with them do not know.

This reduces:

  • Participant expectations.

  • Investigator effects.

  • Biased outcome ratings.


Limitations

Participants may identify the active drug because of side effects.

This can break blinding and create expectation differences between groups.

Clinical samples may also differ in:

  • Severity.

  • Motivation.

  • Other treatment.

  • Social support.

These variables can affect outcomes.


Short-Term Versus Long-Term Effectiveness


Short-Term Effectiveness

Drug therapy may produce rapid changes in:

  • Withdrawal.

  • Craving.

  • Physical stability.

  • Immediate substance use.

These are important during early treatment.


Long-Term Effectiveness

Long-term success involves:

  • Continued abstinence or controlled reduction.

  • Reduced relapse.

  • Stable relationships.

  • Employment or education.

  • Improved mental and physical health.

  • Ability to cope without medication.

A treatment may be highly effective during use but less effective after it stops.

This does not mean the short-term benefit is unimportant.

It means the outcome must be stated accurately.


Appropriateness for Substance Addiction

Drug therapy may be especially appropriate when:

  • Physical dependence is strong.

  • Withdrawal is severe.

  • A receptor system can be targeted.

  • Abrupt cessation would be difficult.

  • The person needs stabilisation.

  • A suitable medication is available.

NRT and methadone fit this pattern because both target biological dependence and withdrawal.


Appropriateness for Behavioural Addiction

Drug therapy may be less directly appropriate where the addiction is maintained mainly through:

  • Cognitive bias.

  • Reinforcement schedules.

  • Social rewards.

  • Learned routines.

  • Emotional escape.

For gambling addiction, CBT may more directly target:

  • The gambler’s fallacy.

  • Illusion of control.

  • Selective recall.

  • Chasing losses.

The AQA June 2024 mark scheme noted that drug therapy was harder to apply to a gambling scenario than behavioural or cognitive methods.


Appropriateness and Motivation

Drug therapy may require less verbal insight than CBT, but motivation still matters.

The person must usually:

  • Begin treatment.

  • Use it consistently.

  • Attend monitoring.

  • Report difficulties.

  • Avoid unsafe combinations.

  • Continue long enough for benefit.

  • Engage with plans for reduction or maintenance.

Medication is not completely passive.


Biological Reductionism

Drug therapy may be criticised for being biologically reductionist.

It treats addiction mainly through:

  • Receptors.

  • Neurotransmitters.

  • Physiological dependence.

  • Withdrawal.

This narrow focus has advantages:

  • Mechanisms can be measured.

  • Treatments can be tested.

  • Symptoms may improve quickly.

  • Medication can be standardised.

However, it may overlook:

  • Learning.

  • Cognition.

  • Relationships.

  • Culture.

  • Personality.

  • Life circumstances.


Biological Determinism

Drug therapy may imply that addictive behaviour is governed by neurochemistry.

This can reduce blame by recognising that withdrawal and craving are not simply weaknesses.

However, a strongly deterministic interpretation may:

  • Make the person feel powerless.

  • Reduce self-efficacy.

  • Encourage reliance on medication alone.

  • Underestimate conscious coping.

A balanced interpretation is:

Biological dependence creates strong pressure, but medication, psychological skills and social support can increase control.

Ethical Issues

Ethical questions include:

  • Informed consent.

  • Side effects.

  • Safe monitoring.

  • Dependency.

  • Appropriate prescribing.

  • The person’s right to refuse.

  • Pressure to take medication.

  • Long-term maintenance.

Treatment should not be selected merely because it is convenient for services.

The individual’s:

  • Goals.

  • Health.

  • preferences.

  • Risks.

  • circumstances.

must be considered.


Economic Implications

Drug therapy may involve costs for:

  • Prescribing.

  • Monitoring.

  • Professional appointments.

  • Long-term maintenance.

  • Managing side effects.

However, effective treatment may reduce wider costs associated with:

  • Repeated healthcare use.

  • Loss of employment.

  • Crime linked with addiction.

  • Family breakdown.

  • Emergency treatment.

Economic evaluation must compare the cost of treatment with the cost of untreated addiction.


Drug Therapy Compared with Behavioural Interventions

Drug therapy

Behavioural interventions

Targets biological processes

Targets learned associations

Reduces withdrawal or reward

Creates aversion or avoidance

May work relatively quickly

Requires repeated conditioning

Particularly suitable for substance dependence

Can be adapted to substances or behaviours

May cause side effects

May produce distress or ethical concerns

Dependency on substitute medication may occur

Effects may not generalise beyond treatment

Does not directly address conditioned cues

Directly changes the response to addiction-related stimuli

Behavioural interventions are examined in aversion therapy and covert sensitisation.


Drug Therapy Compared with CBT

Drug therapy

Cognitive behaviour therapy

Biological intervention

Cognitive and behavioural intervention

Targets receptors, craving and withdrawal

Targets thoughts, triggers and coping

May require less verbal insight

Requires active reflection and practice

Can provide rapid symptom relief

May develop transferable long-term skills

Side effects may occur

Emotional effort and motivation are required

Benefits may depend on continued medication

Skills may remain after therapy

Stronger for physical dependence

Stronger for cognitive and psychological maintenance

The methods may be most effective when combined rather than treated as competitors.


A Combined Treatment Model

Consider a nicotine-dependent smoker:

  1. NRT reduces physical withdrawal.

  2. CBT challenges the belief that smoking is needed for stress.

  3. Cue-management strategies address coffee and work-break triggers.

  4. Social support reduces exposure to smoking peers.

  5. A gradual reduction plan lowers nicotine dependence.

  6. Relapse-prevention strategies prepare for future cravings.

This combined account addresses:

  • Biology.

  • Learning.

  • Cognition.

  • Social influence.


Applying Drug Therapy to a Full Scenario

Callum has smoked heavily for twelve years. When he stops, he becomes restless, irritable and unable to focus. He often relapses within a day. He also smokes whenever he meets colleagues outside work and believes cigarettes are the only way he can relax.

Biological treatment

NRT could provide a controlled nicotine dose.


Mode of action

The nicotine would continue limited stimulation of nicotinic acetylcholine receptors.


Immediate effect

Withdrawal and craving should become more manageable.


Behavioural limitation

Meeting smoking colleagues remains a conditioned cue.


Cognitive limitation

Callum still believes that smoking is necessary for relaxation.


Social limitation

His colleagues model and reinforce smoking.


Balanced treatment

Drug therapy may help him through physical withdrawal, but psychological and social interventions would also be needed.


Overall Evaluation

Drug therapy reduces addiction by altering biological processes involved in reward, physical dependence and withdrawal. Nicotine replacement therapy provides controlled nicotine without cigarette smoking, reducing the sudden loss of nicotinic-receptor stimulation and helping to manage withdrawal. Methadone provides medically controlled opioid-receptor activation, reducing opioid craving and withdrawal.

The approach has a clear biological rationale and may reduce immediate relapse pressure. It can be practical, relatively rapid and particularly appropriate for severe substance dependence. Substitution treatment may also reduce harm and create enough stability for psychological rehabilitation.

However, medication can produce side effects, and substitute drugs may maintain physical dependence. Methadone itself can be addictive and must be reduced carefully. Drug therapy may also treat biological symptoms while leaving conditioned cues, cognitive distortions, stressful environments and social influences unchanged.

Drug therapy is therefore most convincing as one part of an integrated treatment programme. It is particularly useful for managing physical dependence, but lasting recovery may also require cognitive, behavioural and social change.


Common Mistakes āš ļø


Mistake 1

Mistake:Ā Saying drug therapy means immediately removing every addictive substance.

Why this is incorrect:

Some treatments deliberately provide a controlled substitute.

How to improve:

Explain substitution, stabilisation and gradual reduction.


Mistake 2

Mistake:Ā Naming a drug without explaining its mode of action.

Why this is incomplete:

AQA expects some detail about how the treatment works.

How to improve:

Link the drug to receptors, withdrawal, craving or reward.


Mistake 3

Mistake:Ā Saying NRT contains no nicotine.

Why this is incorrect:

NRT supplies nicotine through a controlled product.

How to improve:

State that it avoids cigarette smoking while managing nicotine withdrawal.


Mistake 4

Mistake:Ā Saying NRT removes every smoking cue.

Why this is incorrect:

Coffee, friends and work breaks may remain conditioned stimuli.

How to improve:

Distinguish physical withdrawal from cue reactivity.


Mistake 5

Mistake:Ā Saying methadone is an antagonist that completely blocks opioid receptors.

Why this is inaccurate:

Methadone is an opioid agonist used as a controlled substitute.

How to improve:

Explain that it activates opioid receptors and reduces withdrawal.


Mistake 6

Mistake:Ā Saying methadone instantly cures opioid addiction.

Why this is incorrect:

It may stabilise dependence or support gradual detoxification.

How to improve:

Distinguish maintenance from abstinence.


Mistake 7

Mistake:Ā Saying substitution therapy is automatically unsuccessful because dependence remains.

Why this is too simplistic:

It may reduce serious harm and provide stability.

How to improve:

Balance continuing dependence against controlled use and harm reduction.


Mistake 8

Mistake:Ā Saying side effects prove a treatment is inappropriate.

Why this is incomplete:

Treatment requires a balance of risks and benefits.

How to improve:

Compare side effects with the likely harm of untreated addiction.


Mistake 9

Mistake:Ā Assuming medication addresses every cause of addiction.

Why this is incorrect:

It may leave learning, cognition and social influences unchanged.

How to improve:

Evaluate drug therapy as part of combined treatment.


Mistake 10

Mistake:Ā Applying NRT to gambling addiction.

Why this is inappropriate:

NRT specifically targets nicotine dependence.

How to improve:

Match the treatment to the relevant biological system.


Mistake 11

Mistake:Ā Saying drug therapy requires no motivation.

Why this is inaccurate:

The person must begin, continue and use the treatment appropriately.

How to improve:

Discuss adherence and engagement.


Mistake 12

Mistake:Ā Saying reduced craving proves permanent recovery.

Why this is incorrect:

Craving may return after medication ends, and other causes may remain.

How to improve:

Distinguish short-term symptom reduction from long-term relapse.


Mistake 13

Mistake:Ā Describing only the biological explanation and forgetting treatment.

Why this loses focus:

The question concerns how addiction is reduced.

How to improve:

After each biological point, explain the treatment consequence.


Mistake 14

Mistake:Ā Calling drug therapy effective without identifying an outcome.

Why this is vague:

Effectiveness could mean reduced craving, reduced use, abstinence or improved functioning.

How to improve:

State the outcome being evaluated.


Mistake 15

Mistake:Ā Calling the treatment reductionist without explaining the limitation.

Why this is incomplete:

Evaluation requires development.

How to improve:

Explain that focusing on receptors may overlook conditioned cues, distorted beliefs, stress and peer influence.


Exam-Style Questions āœļø


Question 1

What is meant by drug therapy as a way of reducing addiction? [2 marks]


Question 2

Explain what is meant by substitution therapy. [3 marks]


Question 3

Outline how nicotine replacement therapy may reduce nicotine addiction. [4 marks]


Question 4

Explain how methadone may be used to reduce opioid addiction. [4 marks]


Question 5

Nina becomes restless, irritable and unable to concentrate when she tries to stop smoking. A cigarette quickly removes these symptoms.

Explain how drug therapy might help Nina. [6 marks]


Question 6

Explain one way in which drug therapy is linked to a biological explanation of addiction. [4 marks]


Question 7

A fictional study compared withdrawal scores before and after four weeks of treatment. Higher scores represent more severe withdrawal.

Treatment group

Mean score before treatment

Mean score after treatment

Nicotine replacement therapy

24

12

Placebo

23

19

Calculate the percentage reduction in the mean withdrawal score for the NRT group. Describe one conclusion and explain one limitation of the study. [6 marks]


Question 8

Explain one reason why drug therapy may be more appropriate for nicotine addiction than for gambling addiction. [3 marks]


Question 9

Explain one strength and one limitation of drug therapy as a way of reducing addiction. [6 marks]


Question 10

Discuss drug therapy as a way of reducing addiction. [16 marks]


Answers and Mark Scheme


Question 1

Award one mark for each of the following:

  • Medication is used to alter biological processes involved in addiction.

  • The intended effect is to reduce craving, withdrawal, reward or addictive behaviour.

Maximum: 2 marks


Question 2

Award one mark for each linked point, up to three marks:

  • A harmful or uncontrolled addictive substance is replaced with a medically controlled alternative.

  • The substitute acts on a similar receptor or neurochemical system.

  • It reduces withdrawal or craving.

  • It may be given in a slower or more stable form.

  • The substitute may later be reduced gradually.


Question 3

Award one mark for each relevant point, up to four marks:

  • NRT provides nicotine without cigarette smoking.

  • It may be delivered through a patch, gum, spray or another product.

  • Nicotine continues limited stimulation of nicotinic acetylcholine receptors.

  • This reduces the sudden biological change caused by stopping.

  • Withdrawal and craving become easier to manage.

  • The person is less motivated to smoke to obtain relief.

  • The nicotine dose may be reduced gradually.


Question 4

Award one mark for each relevant point, up to four marks:

  • Methadone is a long-acting opioid medication.

  • It activates opioid receptors.

  • It replaces illicit opioid use in a controlled manner.

  • It reduces withdrawal symptoms.

  • It reduces craving.

  • It may be used for maintenance.

  • It may be reduced gradually during detoxification.

  • It does not immediately remove physical dependence.


Question 5

Award up to six marks for effective application:

  • Nina’s restlessness, irritability and concentration difficulty indicate nicotine withdrawal.

  • Smoking removes the symptoms, so it is negatively reinforced.

  • NRT would provide a controlled nicotine dose.

  • Nicotinic acetylcholine receptors would continue receiving some stimulation.

  • Withdrawal should become less severe.

  • Craving should become more manageable.

  • Nina would no longer need a cigarette to remove the discomfort.

  • A patch could provide steady background nicotine.

  • A fast-acting product could address sudden cravings.

  • The dose could later be reduced.

  • Conditioned smoking cues might still need separate treatment.


Question 6

Possible answer:

Biological explanations propose that addiction is maintained by neurochemical adaptation and withdrawal. For example, repeated nicotine exposure changes nicotinic-receptor functioning, so stopping produces craving and discomfort. NRT supplies a controlled nicotine dose, maintaining limited receptor stimulation and reducing withdrawal. Drug therapy therefore targets the biological process proposed to maintain nicotine addiction.

For four marks, the biological process and treatment action must be connected explicitly.


Question 7

Award up to two marks for the correct calculation:

Reduction=24āˆ’12=12PercentageĀ reduction=2412​×100=50%

The mean withdrawal score decreased by 50%Ā in the NRT group.

Award up to two marks for a conclusion:

  • Withdrawal decreased more in the NRT group than in the placebo group.

  • This is consistent with NRT reducing withdrawal.

  • Controlled nicotine may have reduced the biological effects of abstinence.

  • The result supports a pharmacological effect beyond the placebo condition.

Award up to two marks for a limitation:

  • No measure of dispersion is provided.

  • The sample size is unknown.

  • The groups may have differed in dependence severity.

  • The withdrawal measure may rely on self-report.

  • Participants may have guessed their condition from side effects.

  • Reduced withdrawal does not demonstrate long-term abstinence.

  • Other treatments or social support may have differed.

  • The data are fictional and illustrate interpretation rather than genuine clinical evidence.


Question 8

Award one mark for each linked point, up to three marks:

  • Nicotine addiction involves physical dependence on an ingested substance.

  • Medication can target nicotinic receptors and reduce withdrawal.

  • Gambling does not involve withdrawing from an ingested substance in the same way.

  • Gambling may be maintained more directly by reinforcement schedules and cognitive bias.

  • Psychological treatment may therefore have a more obvious mode of application to gambling.


Question 9

Award up to three marks for one developed strength and up to three marks for one developed limitation.

Possible strength:

Drug therapy directly targets physical dependence. NRT maintains controlled nicotinic-receptor stimulation, while methadone maintains controlled opioid-receptor stimulation. This reduces withdrawal and craving, making immediate relapse less likely and allowing the person to engage with wider treatment.

Possible limitation:

Drug therapy may treat biological symptoms without addressing psychological or social causes. A smoker may experience less withdrawal but still relapse when meeting smoking friends or encountering conditioned cues. The benefits may therefore be short lived unless medication is combined with behavioural or cognitive support.

Other creditworthy limitations include:

  • Side effects.

  • Dependency on a substitute.

  • Adherence.

  • Individual differences.

  • Relapse after medication stops.

  • Biological reductionism.

  • Limited application to behavioural addictions.


Question 10

A high-level response should include accurate knowledge and developed evaluation.


Indicative AO1 Content

  • Definition of drug therapy.

  • Biological nature of medication.

  • Drug therapy targeting receptors or neurotransmitters.

  • Physical dependence.

  • Withdrawal and craving.

  • Agonists.

  • Antagonists.

  • Partial agonists.

  • Substitution therapy.

  • Controlled receptor stimulation.

  • Nicotine replacement therapy.

  • Patches, gum or sprays.

  • Nicotinic acetylcholine receptors.

  • Reduced nicotine withdrawal.

  • Gradual dose reduction.

  • Methadone.

  • Opioid-receptor activation.

  • Maintenance therapy.

  • Detoxification.

  • Reduced opioid withdrawal and craving.

  • Possible medication that blocks reward.

  • Relationship with biological explanations.

  • Combined treatment.


Indicative AO3 Content

  • Direct treatment of physical dependence.

  • Clear biological mode of action.

  • Reduced withdrawal and immediate relapse pressure.

  • Practicality.

  • Harm reduction.

  • Stabilisation.

  • Support for engagement with psychological treatment.

  • Side effects.

  • Cost-benefit analysis.

  • Dependency on substitute medication.

  • Methadone dependence.

  • Treatment of symptoms rather than causes.

  • Conditioned cues remaining.

  • Psychological dependence remaining.

  • Social influences remaining.

  • Adherence problems.

  • Individual differences.

  • Short-term versus long-term effectiveness.

  • Relapse after medication ends.

  • Problems measuring treatment success.

  • Placebo-controlled and double-blind trials.

  • Drug therapy being more directly appropriate for substance addiction.

  • Limited direct application to gambling addiction.

  • Comparison with aversion therapy.

  • Comparison with CBT.

  • Biological reductionism.

  • Biological determinism.

  • Ethical and economic issues.

  • Benefits of combined biological, cognitive and behavioural treatment.


Thirteen to sixteen marks:Ā Knowledge is accurate and generally detailed. At least one named drug treatment and its mode of action are explained clearly. Discussion is thorough and focused, considering appropriateness, effectiveness, side effects, dependency, relapse and alternative treatments. Specialist terminology is used precisely.

Nine to twelve marks:Ā Knowledge is mostly accurate and discussion is generally effective. A named drug and its biological action are explained, although some evaluation may lack depth or balance.

Five to eight marks:Ā Some relevant knowledge is present, but the response is mainly descriptive. Medication may be named without a clear mode of action, or evaluation may rely on undeveloped statements about side effects.

One to four marks:Ā Knowledge is very limited or confused. The answer may claim that drug therapy instantly cures addiction, confuse agonists with antagonists or provide little relevant evaluation.


Recent Posts

See All
Compare approaches in psychology

Question 10 Mark Scheme Compare approaches in psychology. In your answer, refer to their assumptions, explanations of behaviour and scientific investigation. [16 marks] What is expected in the answer?

Ā 
Ā 
Ā 
Discuss the psychodynamic approach in psychology.

Question 10 Mark Scheme Discuss the psychodynamic approach in psychology. Refer to psychosexual stages, the unconscious, personality and defence mechanisms in your answer. [16 marks] What is expected

Ā 
Ā 
Ā 

Comments


bottom of page